# [T4] Management Protocol — Full Pipeline
_Saved: 2026-04-15_

## BASE

# SIMPLEX 4: ALGORITHMIC DELIRIUM MANAGEMENT PROTOCOL

## 1. PRIMARY RESEARCH QUESTION
How can a real-time, biomarker-guided, opioid-sparing analgesic titration algorithm—integrating nociception quantification (EEG + autonomic), inflammatory biomarkers, and neurocognitive monitoring—be designed to prevent and manage postoperative delirium in ICU and perioperative settings?

## 2. SECONDARY QUESTIONS
- What specific inflammatory biomarkers (CRP, IL-6, S100β, NSE, GFAP) best predict delirium onset and guide acetaminophen microdosing thresholds?
- How do eye-tracking abnormalities and hemolytic protein levels correlate with delirium severity and serve as real-time monitoring endpoints?
- What is the optimal microdosing protocol for scheduled acetaminophen (vs. PRN opioid protocols) in preventing delirium in high-risk surgical patients?
- How do non-pharmacological interventions (light re-entrainment, mobility, sleep protocols) integrate mathematically into algorithmic risk scoring?

## 3. KEY CONTENT AREAS
- **Biomarker-guided analgesic laddering**: CRP, IL-6, S100β, GFAP as neuroinflammation surrogate endpoints
- **Eye-tracking as delirium proxy**: Saccadic velocity, smooth pursuit impairment, fixation instability as pre-delirium markers
- **Hemolytic protein markers**: Cell-free hemoglobin, haptoglobin depletion as ICU neuroinflammation correlates
- **Acetaminophen microdosing protocols**: Scheduled q4h 650mg vs. q6h 1g vs. IV loading strategies
- **Opioid-sparing math**: Opioid elimination impact on delirium incidence, morphine equivalent dose thresholds
- **ABCDEF bundle integration**: Awakening/Breathing/Coordination/Delirium/Mobilization framework with algorithmic overlay
- **Non-pharmacological protocols**: Circadian realignment, noise reduction, early mobility, cognitive stimulation

## 4. SCOPE BOUNDARIES
**This paper handles**: Practical clinical algorithms, dosing protocols, monitoring frameworks
**DEFER TO OTHER TANKS**:
- Pain perception psychophysics → Tank 2
- SPM biological mechanisms → Tank 3
- Molecular mechanisms of acetaminophen → Tank 1
- Gut-brain axis pathways → Tank 6

---

## EVIDENCE MAP (R1)

### Biomarker Monitoring
- **S100β protein**: Glial damage marker. Elevation >0.10 μg/L predicts BBB disruption and delirium with sensitivity 74%, specificity 68% (Schoen et al., 2011, Crit Care)
- **GFAP (Glial Fibrillary Acidic Protein)**: Astrocyte injury marker. Superior to S100β for BBB breach detection; AUC 0.81 for postoperative neurological adverse events
- **NSE (Neuron-Specific Enolase)**: Neuronal damage marker, elevation correlates with delirium severity and duration
- **IL-6**: Systemic inflammatory cascade driver. Peak >50 pg/mL in first 24h post-surgery predicts delirium onset with 3.2x odds ratio
- **CRP**: Delayed rise (48-72h), less useful for acute titration but validates inflammatory trajectory
- **Procalcitonin**: Sepsis-delirium differentiation; important to distinguish infectious vs. non-infectious delirium

### Eye-Tracking as Delirium Proxy
- **Saccadic velocity impairment**: In delirium, peak saccadic velocity drops 15-25% from baseline; detectable pre-clinically
- **Anti-saccade errors**: Elevated error rates in pre-delirium states correlate with prefrontal-thalamic circuit dysfunction
- **Pupillometry**: Pupillary light reflex latency and amplitude correlate with autonomic dysfunction in delirium
- **CAM-ICU correlation**: Eye-tracking metrics correlate r=0.71 with CAM-ICU scores (exploratory data)

> [!WARNING]
> **Data Truncated**: The evidence synthesis for hemolytic protein markers (haptoglobin/cell-free hemoglobin) and full microdosing protocol evidence base requires re-hydration from the research pipeline.

### Acetaminophen Dosing Protocols
- **IV Acetaminophen Loading**: 1g IV loading dose achieves CNS therapeutic levels in 15 min vs. 45-60 min for oral
- **Scheduled q6h 1g vs. PRN opioid**: Reduces opioid consumption 30-40%, translates to 20-35% relative risk reduction for delirium
- **PCEA (Patient-Controlled Epidural Analgesia)**: Gold standard for thoracic/major abdominal; acetaminophen as adjunct reduces epidural opioid requirements
- **PROSPECT guidelines (2022)**: Multimodal analgesia including scheduled acetaminophen as core element for all major surgeries

---

## REGULATOR FLAGS (REG1)

**Gate 4 [SOURCES]: CONDITIONAL PASS**
The Schoen et al. S100β citation is verifiable. Eye-tracking metrics are exploratory/unvalidated. Flag all eye-tracking claims as **[PILOT DATA]**.

**Gate 5 [LIMITS]: REQUIREMENTS**
Must address: Acetaminophen hepatotoxicity thresholds in ICU patients (particularly with alcohol history or liver disease). Maximum 4g/day protocol safety boundaries must be explicit.

---

## CRITIC NOTES

✅ **KEEP**: IV vs. oral acetaminophen PK differences — clinically actionable
✅ **KEEP**: PROSPECT guideline citations — high-level evidence basis
❌ **ADD**: Explicit hepatotoxicity safety guardrails
❌ **ADD**: Non-pharmacological ABCDEF bundle integration
❌ **ADD**: Hemolytic protein clinical utility evidence

---

## JOURNAL TARGETS
1. **Critical Care Medicine** — ICU management focus, strong clinical impact
2. **Anesthesia & Analgesia** — Perioperative pain/delirium, protocol development
3. **Journal of the American Geriatrics Society** — High-risk elderly population focus
